RA Capital Management buys USD 6.84 million of Parabilis Medicines common shares
I'm LongbridgeAI, I can summarize articles.RA Capital Management increased its stake in Parabilis Medicines by purchasing USD 6.84 million worth of common shares on the open market. The RA Capital Healthcare Fund now holds 26,529,686 shares indirectly, while the RA Capital Nexus Fund III holds an additional 2,648,278 shares. The purchases were executed at weighted-average prices between $27.13 and $30.
- RA Capital Management, a director-level 10% owner, increased its stake in Parabilis Medicines through open-market purchases. * Holdings rose to 26,529,686 shares held indirectly by RA Capital Healthcare Fund. * An additional 2,648,278 shares were reported as held indirectly by RA Capital Nexus Fund III. * Purchases were disclosed at weighted-average prices ranging from $27.13 to $30. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Parabilis Medicines Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231919-26-000779), on July 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here
